The FDA has approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for treating major depressive ...

Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, ...

The FDA has approved linaclotide (Linzess) capsules for treating irritable bowel syndrome with constipation (IBS-C) in ...

Researchers have found in a new study that older adults with poor olfaction, or a reduced sense of smell, are at a ...

A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with ...

Researchers have identified obesity hypoventilation syndrome (OHS) in a small but clinically relevant number of patients who ...

China: A new study has revealed that bleeding during early pregnancy is associated with an increased risk of fetal ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...

A new real-world observational study by Abraham A., Dhar R., and colleagues, published in Journal of Dermatology Research ...

The research, published in BMC’s Diabetology & Metabolic Syndrome by Diar Zooravar from the School of Medicine, Iran ...

GlaxoSmithKline Pharmaceuticals has recorded a 2 percent year-on-year rise in net profit to Rs 255 crore for the quarter ...

In a significant regulatory development, Torrent Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) ...